What Is The Best Time Sampling For The Two Direct Oral Anticoagulants, Dabigatran and Rivaroxaban?

被引：0
|
作者：
Douxfils, Jonathan
Classen, Jean-Francois
Baudar, Justine
Devalet, Berangere
Samama, Meyer Michel
Chatelain, Bernard
Dogne, Jean-Michel
Mullier, Francois
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4805
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparing Medication Adherence Tools for the Direct Oral Anticoagulants Rivaroxaban and Apixaban
    Castellucci, Lana A.
    Chiang, Philip
    Pecarskie, Amanda
    Le Gal, Gregoire
    Rodger, Marc
    BLOOD, 2017, 130
  • [32] A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma
    Lagoutte-Renosi, Jennifer
    Le Poupon, Julien
    Girard, Alexandra
    Montange, Damien
    Davani, Siamak
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2018, 1100 : 43 - 49
  • [33] Direct oral anticoagulants: What will be their role in children?
    Male, Christoph
    Thom, Katharina
    O'Brien, Sarah H.
    THROMBOSIS RESEARCH, 2019, 173 : 178 - 185
  • [34] Antidotes for the direct oral anticoagulants: What news?
    Galliazzo, S.
    Donadini, M. P.
    Ageno, W.
    THROMBOSIS RESEARCH, 2018, 164 : S119 - S123
  • [35] What role for the direct oral anticoagulants in oncology?
    Lebellec, Loic
    Kouakam, Claude
    Bertrand, Nicolas
    Penel, Nicolas
    BULLETIN DU CANCER, 2018, 105 (7-8) : 631 - 633
  • [36] A nationwide Belgian survey on the influence of the new oral anticoagulants dabigatran and rivaroxaban on commonly used coagulation assays
    Van Blerk, M.
    Bailleul, E.
    Chatelain, B.
    Demulder, A.
    Devreese, K.
    Douxfils, J.
    Jochmans, K.
    Mullier, F.
    Wijns, W.
    Soumali, M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 263 - 263
  • [37] Drug interactions of newer oral anticoagulants dabigatran, rivaroxaban, and apixaban with routinely used nonanticoagulant/antiplatelet drugs
    Sayani, S.
    Iqbal, O.
    Hoppensteadt, D.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 897 - 897
  • [38] Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty
    Lars C. Borris
    Archives of Orthopaedic and Trauma Surgery, 2010, 130 : 583 - 589
  • [39] Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty
    Borris, Lars C.
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2010, 130 (05) : 583 - 589
  • [40] Drug Interactions of Newer Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban with Routinely Used Nonanticoagulant/Antiplatelet Drugs
    Sayani, Shermin
    Iqbal, Omer
    Hoppensteadt, Debra
    Fareed, Jawed
    BLOOD, 2014, 124 (21)
12345